The GliomaEd.com advisory board comprises renowned academic and clinical leaders in the fields of radiation oncology, neuro-oncology, and neurosurgery. The following advisory board members contribute and review content for GliomaEd.com:

Arnab Chakravarti, MD, Associate Professor of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, Boston, MA.

Matthew G. Ewend, MD, Associate Professor and Chief, Division of Neurosurgery, University of North Carolina, Chapel Hill, NC.

Andrew B. Lassman, MD, Assistant Professor, Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY.

William F. Regine, MD, Professor and Chairman, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD.

Volker W. Stieber, MD, Assistant Professor, Department of Radiation Oncology, Wake Forest University, Winston-Salem, NC.

Michael A. Vogelbaum, MD, PhD, Associate Director, Neurosurgical Oncology, Cleveland Clinic, Cleveland, OH.

Disclosure Statements

Dr. Chakravarti has no relevant commercial relationship to disclose.

Dr. Ewend discloses that he is on an advisory board for MGI Pharma, Inc.

Dr. Lassman discloses that he is on advisory committees for Enzon, Guilford/MGI, and Schering-Plough. He is also on a speakers’ bureau for Schering-Plough.

Dr. Regine discloses that he is on a speakers’ bureau for Schering-Plough.

Dr. Stieber discloses that he is on advisory committees for Cytyc Corporation and Monteris Medical.

Dr. Vogelbaum discloses that he is on advisory committees for MGI Pharma, NeoPharm, and Schering-Plough. He is also on a speakers’ bureau for Schering-Plough.